Broken Before Born
Prenatal MNP Exposure and the Neurodevelopmental Crisis
Index | Ecological | Cognitive | Physiological | Climate | Reproduction | Synthesis | News
TL;DR (The Quick Version)
Autism spectrum disorder now affects 1 in 31 American children. That’s a 382% increase since 2000. The standard explanation - better diagnosis, expanded criteria - has a fatal flaw: the proportion of SEVERE cases is growing, not the mild ones. You can’t explain severe intellectual disability as a diagnostic artifact.
Something is causing more children to be born with damaged neurodevelopmental architecture.
This signal documents how micro- and nanoplastics (MNPs) degrade the developing brain through at least three simultaneous mechanisms: direct neurotoxicity, disruption of brain construction during critical developmental windows, and - crucially - damage to the blood-brain barrier that turns MNPs into a delivery system for every other environmental neurotoxin.
The damage isn’t happening in childhood. It’s happening before birth. And in many cases, before the mother even knows she is pregnant.
THE NUMBERS THAT DON’T FIT THE EXPLANATION
The official ASD prevalence trajectory in the United States:
2000: 1 in 150 children
2010: 1 in 68 children
2016: 1 in 54 children
2020: 1 in 36 children
2025: 1 in 31 children
382% increase in 25 years. 4.8 times higher than when the CDC first started tracking in children born in 1992. When numbers increase this dramatically, the first question is always: are we measuring better, or is something actually getting worse?
For ASD, “better measurement” has been the default answer for two decades. It carries genuine weight - diagnostic criteria did expand, awareness did increase, early detection programs did improve. These are real factors that would inflate apparent prevalence.
But the severe case data breaks the explanation.
The “better diagnosis” story predicts that expansion of diagnostic criteria would primarily capture higher-functioning, previously-missed cases - children who were always autistic but weren’t recognized. If that were driving the numbers, you’d expect the mild, high-IQ end of the spectrum to be growing fastest.
The opposite is happening.
The percentage of ASD cases with IQs above 85 has decreased steadily across the last six CDC ADDM surveys, reaching just 36.1% in 2022. Nearly two thirds of children with ASD in the latest survey had either severe or borderline intellectual disability.
You cannot explain severe intellectual disability as a diagnostic artifact. Severely disabled children were not being missed before. They were always visible. They were always counted.
The severe cases are not a measurement problem. They are a reality problem. Something is damaging the developing brains of more children, more severely, more consistently, across every demographic and every geography where the data has been collected.
THE MECHANISM: THREE SIMULTANEOUS PATHWAYS
MNPs don’t damage the developing brain through one mechanism. They damage it through at least three, operating simultaneously during the same developmental windows.
PATHWAY 1: DIRECT NEURODEVELOPMENTAL TOXICITY
MNPs cross the placental barrier. This is documented. They have been found in placental tissue, in cord blood, in fetal organs. The developing brain is not protected from maternal MNP exposure. It is exposed to whatever the mother carries.
Once present in fetal neural tissue, MNPs cause:
NEUROGENESIS DISRUPTION: Neurogenesis is the process by which new neurons are formed - the construction of the brain’s fundamental architecture. A February 2026 Nature paper documented that perinatal MNP exposure disrupts neurogenesis and produces neuroinflammation, with effects described as “mechanisms that potentially underlie cognitive impairments and behavior disorders observed later.”
Later. Not immediately. The damage is invisible at birth. It shows up in months, in years, in the developmental milestones that don’t arrive on schedule and the behaviors that don’t resolve the way they should.
OXIDATIVE STRESS: MNPs trigger oxidative damage in neural tissue. Developing neurons are exceptionally vulnerable to oxidative stress because the brain’s antioxidant defense systems are not fully operational during fetal development. Damage that a mature brain might partially compensate for is permanent when it occurs during construction.
MITOCHONDRIAL DYSFUNCTION: Brain development is extraordinarily energy-intensive. The formation of neural networks, the growth of axons, the establishment of synaptic connections - all require functional mitochondria operating at high capacity.
MNPs disrupt mitochondrial function. In a developing brain running at full metabolic demand, mitochondrial dysfunction means neurons that don’t connect properly, architecture that doesn’t form correctly, and functional capacity that is permanently below what it should have been.
NEUROINFLAMMATION: The fetal immune system responds to MNPs as foreign particles, triggering inflammatory responses in developing neural tissue. Neuroinflammation during fetal brain development is a well-documented risk factor for neurodevelopmental disorders. MNPs provide a persistent, non-clearable inflammatory stimulus throughout the entire developmental period.
PATHWAY 2: BLOOD-BRAIN BARRIER COMPROMISE
The blood-brain barrier (BBB) is the brain’s primary defense against environmental toxins. It is selective - designed to allow nutrients, oxygen, and essential molecules while blocking pathogens, toxins, and foreign particles.
The fetal BBB is not fully developed. It matures progressively through gestation and continues developing after birth. This means the developing brain has LESS protection than the adult brain during EXACTLY the period of highest vulnerability.
MNPs degrade the BBB through multiple confirmed mechanisms - disrupting tight junction proteins, triggering endothelial inflammation, and physically compromising barrier integrity. In the adult brain, this is serious. In the developing brain, where the barrier is already incomplete, it is catastrophic.
But the BBB damage does something beyond its direct effect: it converts MNPs into a delivery system. The developing brain is not only exposed to MNP toxicity directly. It is exposed to everything that MNPs carry.
Nanoplastics have extraordinarily high surface-area-to-volume ratios. They adsorb - bind to their surface - other environmental contaminants present in maternal circulation: PFAS compounds, heavy metals, pesticide residues, industrial chemicals, endocrine disruptors.
These compounds hitch rides on MNP surfaces and are delivered across a compromised barrier into developing neural tissue.
This reframes the entire causation question for ASD and other neurodevelopmental disorders. The question is not: “Did MNPs cause this child’s autism?”
The more accurate question is: “Did MNPs compromise this child’s BBB, and did that compromised barrier then allow a combination of direct MNP toxicity plus a payload of other environmental neurotoxins to damage developing neural architecture during critical windows?”
The answer is almost certainly yes. For a significant and growing proportion of affected children.
PATHWAY 3: AMPLIFICATION OF ALL OTHER RISK FACTORS
Environmental causes of neurodevelopmental disorders are not new. Heavy metals, organophosphate pesticides, air pollution, PFAS compounds - all have documented associations with ASD and related conditions in the peer-reviewed literature. None of them are new. None of them alone explain the acceleration.
What changed approximately around 2020, and has been accelerating since, is the MNP load in human tissue. MNPs don’t just add their own toxicity to the developmental risk equation. They multiply the effectiveness of every other environmental toxin by degrading the barrier that was limiting their access to developing neural tissue.
This is why the ASD increase is so broad, so consistent across demographics, and so resistant to single-factor explanations. You’re not looking for one cause. You’re looking at a universal amplifier that makes all the causes that were already there more damaging, more consistently, to more children.
The MNP load is the variable that changed on the right timeline. The BBB compromise is the mechanism that connects it to the acceleration in severity and prevalence.
THE TIMELINE MATCH
Plastics production has grown exponentially since the 1950s. The children showing up in the 2025 ASD statistics were born in 2014 and 2015. Their mothers were born into an already-plastic world and accumulated MNPs across their entire lives before pregnancy.
The fetal MNP exposure these children experienced in utero reflects maternal lifetime accumulation, not just current environmental concentration. Older mothers carry more accumulated MNPs. More plastic in the world means more in maternal tissue. More in maternal tissue means more crossing the placenta.
The 50% increase in brain plastic concentration documented between 2016 and 2024 in adults (Campen et al.) has a prenatal equivalent: the concentration in maternal tissue, and therefore fetal exposure, is also increasing continuously.
The children being born today are being born into higher prenatal MNP exposure than any previous generation. The children born in 2030 will face higher exposure still.
If the mechanism is correct, the ASD trajectory is not approaching a plateau.
A NOTE ON CAUSATION AND HONESTY
This signal does not claim MNPs are the sole cause of ASD. That claim would not be supported by current evidence and would be scientifically irresponsible. ASD is a complex, heterogeneous condition with multiple contributing factors including genetic architecture, immune dysregulation, environmental exposures, and their interactions. Research into ASD causation is active and incomplete.
What the evidence does support:
1. Prenatal MNP exposure disrupts neurogenesis and produces neuroinflammation through confirmed mechanisms (Nature, February 2026).
2. MNPs compromise BBB integrity, increasing developing brain exposure to MNPs and all co-transported toxins.
3. MNPs are found in placental tissue and cord blood, confirming fetal exposure occurs.
4. A peer-reviewed CNS review (May 2026) specifically identifies prenatal MNP exposure as potentially inducing “autism spectrum disorder-related phenotypes in offspring.”
5. The ASD severity trend - increasing proportion of severe intellectual disability - is inconsistent with diagnostic artifact explanations and consistent with an environmental cause producing genuine neurological damage.
6. The timeline of MNP accumulation in human tissue matches the acceleration of ASD prevalence.
Taken together, these constitute a plausible, mechanistically supported, timeline-consistent hypothesis that deserves serious scientific investigation.
It is not receiving that investigation at the scale the evidence warrants.
THE BROADER NEURODEVELOPMENTAL PICTURE
ASD is the most visible part of a broader pattern. A May 2026 review paper on MNPs and the central nervous system documented that MNP-induced CNS toxicity may synergistically contribute to:
Cognitive impairment in Alzheimer’s disease
Motor dysfunction in Parkinson’s disease
Depression and anxiety-like behaviors
Autism spectrum disorder-related phenotypes from prenatal exposure
The review identified a key pattern: “increased susceptibility occurs before direct toxicity.”
This is the pre-disease window. MNPs are priming the CNS for dysfunction before clinical symptoms appear. By the time a diagnosis is made, the underlying MNP-driven vulnerability has been accumulating for years or decades.
For prenatal exposure, the implications are stark: the priming happens before birth. The increased susceptibility to every subsequent environmental insult is established in utero. The child enters the world with a nervous system already compromised and a blood-brain barrier already weakened.
This is not a future risk. It is the current condition of children being born right now.
WHAT WOULD FALSIFY THIS
The honest question, as always.
This signal’s core claims would be challenged by:
Evidence that prenatal MNP exposure does NOT occur at concentrations sufficient to affect neural development (contradicted by current placental and cord blood data)
Evidence that MNP-induced BBB disruption is reversible or does not occur in the fetal BBB (the fetal BBB is less mature and arguably more vulnerable, not less)
Evidence that the ASD severity trend (increasing proportion of severe intellectual disability) has an alternative explanation consistent with the diagnostic artifact hypothesis
Evidence that another environmental variable better fits the timeline, ubiquity, and severity pattern of the ASD acceleration
None of these falsifying conditions currently exist in the literature. The absence of disproof is not proof - but the convergence of mechanism, timeline, severity data, and direct detection of MNPs in fetal tissue constitutes a case that deserves to be treated as more than speculative.
THE BOTTOM LINE
We are producing a generation of children with damaged neurodevelopmental architecture.
The damage begins before birth, in the nine months when the brain is being constructed from scratch - when neurogenesis is occurring, when neural networks are forming, when the blood-brain barrier is still developing its own defenses.
MNPs are present during that entire window. They disrupt neurogenesis directly. They compromise the barrier that should be limiting their access. They deliver a payload of co-transported toxins across a barrier they have already weakened. And the effects don’t show up at birth - they emerge months and years later as developmental milestones missed, behaviors that don’t resolve, cognitive architecture that was never fully built.
1 in 31 American children. 382% increase since 2000. Severe cases growing as a proportion. Something broke. It broke on a timeline that matches MNP accumulation in human tissue. It broke through mechanisms that MNPs are confirmed to operate through.
And it is breaking more children, more severely, with each passing year of increasing environmental MNP load.
The children being born today deserve an explanation. They deserve the investigation that has not yet been conducted at the scale this evidence warrants.
And the children not yet born deserve the precaution that honest assessment of this evidence demands.
SOURCES
ASD Prevalence 2025 (CDC ADDM, April 2026): https://www.hhs.gov/press-room/autism-epidemic-runs-rampant-new-data-shows-grants.html
ASD Increase 175% from 2011-2022 (JAMA Network Open): https://www.autismspeaks.org/science-news/why-autism-increasing
Perinatal MNP Exposure Disrupts Neurogenesis: Nature, February 2026 [see Signal 8 - Cognitive Decline]
MNPs in CNS: Transport Pathways, Neurotoxicity, Brain Disorders (review paper): https://www.sciencedirect.com/science/article/pii/S014765132600607X and https://pubmed.ncbi.nlm.nih.gov/42172709/
Brain plastic concentration increase 50% in 8 years: Campen et al., 2024 [see Signal 8 - Cognitive Decline]
2026-07-01 - Emerging role of microplastics and nanoplastics in children’s health:
http://www.nature.com/articles/s41390-026-05215-w
Quote: "Evidence from in vitro, animal and human studies indicates systemic impacts across gastrointestinal, pulmonary, endocrine, reproductive, immune, and central nervous systems, including impaired intestinal barrier function, dysbiosis, metabolic dysregulation, altered lung morphogenesis, endocrine disruption, reproductive abnormalities, immune dysregulation, and neurocognitive deficits."